The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

July 13, 2016 • By Joerg Ermann, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Brook Coppola

(click for larger image)
Figure 1: The MHC Class I Antigen Presentation Pathway: TCR = T cell receptor, b2m = beta 2 microglobulin, ER = endoplasmic reticulum, TAP = transporter associated with antigen processing.
Brook Coppola

The mechanistic link between human leukocyte antigen B27 (HLA-B27) and ankylosing spondylitis (AS) is one of the great enigmas in rheumatology. The introduction of biological therapies that target tumor necrosis factor (TNF) or the interleukin (IL) 23/IL-17A axis has had a major impact on the quality of life for many patients with AS, and one might ask: Why should we care about HLA-B27 at all?

You Might Also Like
  • Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis
  • Letters: UCLA Study on HLA-B27 Link with Ankylosing Spondylitis at Forefront
  • Researchers Explore HLA-B27’s Role in the Development of Spondylitis
Explore This Issue
July 2016

Inhibitors of TNF or the IL-23/IL-17A axis are broadly effective in AS. However, they expose patients to the risks of chronic immunosuppression and place a substantial financial burden on the healthcare system. The focus of research, therefore, has to shift toward finding a cure or preventing the disease, which is unlikely to happen without a detailed understanding of the role of HLA-B27 in AS pathogenesis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This article provides an overview of HLA-B27 research, highlighting important historical landmarks and recent advances.

Discovery of the HLA-B27 Association

In the early 1970s, serological methods originally developed for histocompatibility testing in the organ transplantation field were applied to rheumatic diseases. This resulted in the discovery of the association between HLA-B27 and AS in 1973 by groups in Los Angeles and London.1-3 Subsequently, HLA-B27 was shown to be associated with other types of spondyloarthritis (SpA) or SpA-related disorders as well, namely psoriatic arthritis, reactive arthritis and uveitis.4-7

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

HLA testing at that time was done with sera from multiparous women, who had become immunized against paternally derived antigenic determinants present on cells of the fetus.

The nature of the antigenic targets remained unknown until the mid-1980s, when the sequences of the HLA genes, including HLA-B27, were determined.8,9 Soon thereafter, it was discovered that the serologically defined HLA-B27 entity was in fact a family of related alleles with minor differences in their amino acid and/or nucleotide sequences and that some of these subtypes were not associated with AS (see below).

MHC Class I Antigen Presentation

HLA-B27 is an allelic variant of the HLA-B gene located in the major histocompatibility complex (MHC) on human chromosome 6p21. The MHC is a highly polymorphic region containing many genes involved in adaptive and innate immunity. HLA-B and the closely related HLA-A and HLA-C genes are located in the class I subregion of the MHC. HLA-A, HLA-B and HLA-C encode the heavy chain (HC) component of MHC class I molecule. MHC class I molecules are heterotrimeric complexes of the highly polymorphic HC, the non-polymorphic beta 2 microglobulin (b2m), which is encoded outside the MHC on chromosome 15, and a peptide of 8–9 amino acid length. The peptide lies in a groove formed by two HC alpha helices on the apical surface of the complex.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 7 8 9 | Single Page

Filed Under: Conditions, Spondyloarthritis, Systemic Inflammatory Syndromes Tagged With: Ankylosing Spondylitis, HLA-B27Issue: July 2016

You Might Also Like:
  • Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis
  • Letters: UCLA Study on HLA-B27 Link with Ankylosing Spondylitis at Forefront
  • Researchers Explore HLA-B27’s Role in the Development of Spondylitis
  • Gut Instinct: Ankylosing Spondylitis & the Microbiome

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Patient & Caregiver Resources

Find a rheumatology provider. Learn about your condition and how to live with it. English and Spanish language resources.

View Patient & Caregiver Resources »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)